Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105048
Filing Date
2025-08-07
Accepted
2025-08-07 16:16:48
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20250630.htm   iXBRL 10-Q 2359447
2 EX-31.1 orgo-ex31_1.htm EX-31.1 16573
3 EX-31.2 orgo-ex31_2.htm EX-31.2 17183
4 EX-32.1 orgo-ex32_1.htm EX-32.1 17650
  Complete submission text file 0000950170-25-105048.txt   9384950

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20250630.xsd EX-101.SCH 1352843
80 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20250630_htm.xml XML 1612981
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 251194276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)